TITLE

SECTION 7 METABOLIC DISORDERS

PUB. DATE
September 2014
SOURCE
MPR - Pharmacist's Edition;Fall2014, Vol. 8 Issue 3, p131
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on several drugs for the treatment of obesity. The Belviq weight-loss medication from pharmaceutical firm Eisai Co. Ltd. should be used together with a reduced-calorie diet and weight maintenance to treat obesity. Obese patients are advised to take the Qsymia weight loss pill once a day in the morning and its adverse reactions include paraesthesia. The contraindications of the Xenical lipase inhibitor include chronic malabsorption syndrome and pregnancy.
ACCESSION #
98790981

 

Related Articles

  • Topiramate withdrawal.  // Reactions Weekly;6/2/2007, Issue 1154, p22 

    The article presents a case report of an obese man who experienced rebound weight gain following topiramate withdrawal. The man had a body mass index of 32 and a history of multiple dietary treatments followed by weight gain and an unsuccessful orlistat treatment. The man stopped further...

  • The uphill battle facing antiobesity drugs. Daubresse, M; Alexander, G C // International Journal of Obesity;Mar2015, Vol. 39 Issue 3, p377 

    The authors reflect on the limited adoption of antibobesity drugs in clinical practice in the U.S. despite their association with short-term weight loss. They cite several antiobesity drugs that were withdrawn from the market due to the occurrence of adverse effects including sibutramine and...

  • Managing obesity in adults in primary care. Plourde, Gilles; Prud'homme, Denis // CMAJ: Canadian Medical Association Journal;6/12/2012, Vol. 184 Issue 9, p1039 

    In this article, the author presents his views on the prevention and treatment of obesity and also believes that weight loss counseling must be a part of primary care for adults. He mentions that the two most common methods of assessing obesity and overweight are body mass index (BMI) and waist...

  • Obesity: Health costs estimated at $75 billion.  // Drug Store News;8/28/2006, Vol. 28 Issue 10, p50 

    The article provides an overview of the anti-obesity drug market in the United States. Data showed that 32 percent of American adults are obese, which represents more than 60 percent increase in the prevalence of obesity since 1993. Overweight and obesity are associated with an increased risk of...

  • Evaluation of Safety and Anti-obese Activity of a Polyherbal Formulation -- Simlim Capsule. Shah, Bijal N.; Soni, Hardik K.; Patel, Ghanshyam R.; Patel, Pooja D.; Paranjape, Archana N. // International Journal of Pharmaceutical & Phytopharmacological R; 

    Obesity is one the most common and now considered as global health problem which triggers many other metabolic disorders. In the present study, a polyherbal formulation - Simlim Capsule was evaluated for its anti-obesity activity in high fat diet (HFD) induced male Wistar albino rats. It was...

  • Choosing the Right Weight Loss Medication for Your Patient Requires Careful Consideration. Still, Christopher // Bariatric Times;Dec2015, Vol. 12 Issue 12, p3 

    The author discusses how to match a patient with the right weight loss medication given his risk, medical history and preferences. He cites the 5 Food and Drug Administration (FDA) approved pharmacotherapy options for treating obesity including phentermine, orlistat and phentermine/topiramate...

  • INSIDE AMERICA'S HOTTEST DIET PROGRAMS. Donahue, Peggy Jo // Prevention;Feb90, Vol. 42 Issue 2, p55 

    Looks at Nutri/System, a comprehensive weight-loss and weight-maintenance program. Role in helping people to move from an inactive to an active lifestyle; Two phases of the Nutri/System program; Importance of a high-carbohydrate, low-fat, low-sodium diet regimen; Advantages of the Nutri/System...

  • Does Finasteride Cause Permanent Sexual Side Effects?  // Neurology Alert;Sep2012, Vol. 31 Issue 1, Special section p1 

    This section offers news briefs pertaining to pharmacology as of September 2012. A study found that finasteride, a drug used to treat male pattern baldness and symptomatic benign prostatic hypertrophy, may cause long-term sexual dysfunction. A federal appeals court in Philadelphia, Pennsylvania...

  • ORLISTAT. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p626 

    The article presents information on orlistat, an antiobesity drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics